PH12018500323A1 - Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds - Google Patents

Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds

Info

Publication number
PH12018500323A1
PH12018500323A1 PH12018500323A PH12018500323A PH12018500323A1 PH 12018500323 A1 PH12018500323 A1 PH 12018500323A1 PH 12018500323 A PH12018500323 A PH 12018500323A PH 12018500323 A PH12018500323 A PH 12018500323A PH 12018500323 A1 PH12018500323 A1 PH 12018500323A1
Authority
PH
Philippines
Prior art keywords
pyrrolo
imidazol
dihydro
substituted
antibacterial compounds
Prior art date
Application number
PH12018500323A
Other languages
English (en)
Inventor
Anne-Catherine Blumstein
Gaelle Mathieu
Loic Jacob
Florence Masse
Azely Mirre
Philippe Panchaud
Christine Schmitt
Jean-Luc Specklin
Jean-Philippe Surivet
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of PH12018500323A1 publication Critical patent/PH12018500323A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH12018500323A 2015-09-03 2018-02-13 Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds PH12018500323A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2015070144 2015-09-03
PCT/EP2016/070695 WO2017037221A1 (en) 2015-09-03 2016-09-02 Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds

Publications (1)

Publication Number Publication Date
PH12018500323A1 true PH12018500323A1 (en) 2018-08-13

Family

ID=56852279

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12018500323A PH12018500323A1 (en) 2015-09-03 2018-02-13 Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds

Country Status (17)

Country Link
US (1) US10314823B2 (enExample)
EP (1) EP3344630B1 (enExample)
JP (1) JP2018526391A (enExample)
KR (1) KR20180049017A (enExample)
CN (1) CN108137596A (enExample)
AR (1) AR105889A1 (enExample)
AU (1) AU2016313794B2 (enExample)
BR (1) BR112018004343A2 (enExample)
CA (1) CA2994996A1 (enExample)
CL (1) CL2018000533A1 (enExample)
EA (1) EA201890626A1 (enExample)
HK (1) HK1256614A1 (enExample)
IL (1) IL257757A (enExample)
MX (1) MX2018002644A (enExample)
PH (1) PH12018500323A1 (enExample)
TW (1) TW201714885A (enExample)
WO (1) WO2017037221A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
TW201840569A (zh) * 2017-03-01 2018-11-16 瑞士商愛杜西亞製藥有限公司 (2r)-n-羥基-4-(6-((1-(2-羥基乙基)氮雜環丁烷-3-基)丁-1,3-二炔-1-基)-3-氧基-1h-吡咯并[1,2-c]咪唑-2(3h)-基)-2-甲基-2-(甲磺醯基)丁醯胺之結晶形式
WO2018224455A1 (en) 2017-06-07 2018-12-13 Basf Se Substituted cyclopropyl derivatives
WO2019038362A1 (en) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
WO2019086452A1 (en) 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds
WO2019121143A1 (en) 2017-12-20 2019-06-27 Basf Se Substituted cyclopropyl derivatives
JP7156199B2 (ja) * 2018-08-09 2022-10-19 信越化学工業株式会社 レジスト材料及びパターン形成方法
WO2020243415A2 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
MX2021014441A (es) 2019-05-31 2022-01-06 Ikena Oncology Inc Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
WO2021102314A1 (en) * 2019-11-21 2021-05-27 University Of Utah Research Foundation Trpv4 receptor ligands

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008893A (es) 2002-03-13 2005-06-20 Array Biopharma Inc Derivados de bencimidazol n3 alquilados como inhibidores de mek.
UA80500C2 (en) 2003-10-17 2007-09-25 Basf Ag Fungicidal mixture and agent for controlling rice pathogens, containing triazolopyrimidine derivative and metalaxyl-m, method for controlling rice pathogens and sowing material
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
JP5671545B2 (ja) 2009-10-13 2015-02-18 ファイザー・インク 抗菌薬として有用なc結合ヒドロキサム酸誘導体
JP5793766B2 (ja) * 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なn−結合型ヒドロキサム酸誘導体
US8853213B2 (en) 2011-01-03 2014-10-07 Hanmi Pharm. Co., Ltd Bicyclic compound for modulating G protein-coupled receptors
AP3336A (en) * 2011-03-07 2015-07-31 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
JP2014514299A (ja) 2011-04-08 2014-06-19 ファイザー・インク 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体
CN103717582B (zh) 2011-04-08 2015-09-30 辉瑞大药厂 用作抗菌剂的异*唑衍生物
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014078609A1 (en) 2012-11-16 2014-05-22 Bristol-Myers Squibb Company Pyrrolidine gpr40 modulators
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
WO2015066413A1 (en) 2013-11-01 2015-05-07 Novartis Ag Oxazolidinone hydroxamic acid compounds for the treatment of bacterial infections
CA2933604A1 (en) 2013-12-19 2015-06-25 Actelion Pharmaceuticals Ltd Antibacterial 1h-indazole and 1h-indole derivatives
AR099612A1 (es) * 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
KR20170005105A (ko) 2014-05-16 2017-01-11 액테리온 파마슈티칼 리미티드 항균성 퀴나졸린-4(3h)-온 유도체
AU2015349005A1 (en) 2014-11-19 2017-07-06 Idorsia Pharmaceuticals Ltd Antibacterial benzothiazole derivatives
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AU2016314963A1 (en) 2015-08-28 2018-04-19 Idorsia Pharmaceuticals Ltd Antibacterial annulated pyrrolidin-2-one derivatives
AR105848A1 (es) 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
EP3386950A1 (en) 2015-12-08 2018-10-17 GlaxoSmithKline Intellectual Property Development Limited Substituted benzazinones as antibacterial compounds
AR108488A1 (es) 2016-05-17 2018-08-22 Idorsia Pharmaceuticals Ltd Derivados 6-(buta-1,3-diin-1-il)benzo[d]tiazol

Also Published As

Publication number Publication date
CL2018000533A1 (es) 2018-06-29
EA201890626A1 (ru) 2018-09-28
AR105889A1 (es) 2017-11-22
BR112018004343A2 (pt) 2018-09-25
IL257757A (en) 2018-04-30
WO2017037221A1 (en) 2017-03-09
TW201714885A (zh) 2017-05-01
CA2994996A1 (en) 2017-03-09
EP3344630A1 (en) 2018-07-11
HK1256614A1 (zh) 2019-09-27
JP2018526391A (ja) 2018-09-13
EP3344630B1 (en) 2020-12-09
AU2016313794A1 (en) 2018-04-19
US10314823B2 (en) 2019-06-11
KR20180049017A (ko) 2018-05-10
AU2016313794B2 (en) 2020-06-04
CN108137596A (zh) 2018-06-08
MX2018002644A (es) 2018-06-20
US20180250273A1 (en) 2018-09-06

Similar Documents

Publication Publication Date Title
PH12018500323A1 (en) Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
MX380239B (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona.
EA201691913A1 (ru) Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов
MX378288B (es) Inhibidores de pirimidina del fgfr4.
PH12016500643A1 (en) New octahydro - cyclobuta [1,2-c;3,4-c`] dipyrrol -2- yl
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
HK1217492A1 (zh) 作爲刺猬信号通路抑制剂的杂环化合物
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
EA201692521A1 (ru) Пиразольные соединения и их применение в качестве блокаторов кальциевых каналов т-типа
EA201692525A1 (ru) Замещенные соединения [1,2,4]триазола и имидазола в качестве фунгицидов
MX2016005760A (es) Inhibidores de glucogeno sintasa cinasa 3 (gsk-3).
PH12018500301A1 (en) Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterials
EA201691775A1 (ru) Производные 1,2-дигидро-3н-пирроло[1,2-с]имидазол-3-она и их применение в качестве антибактериальных средств
PH12016500347A1 (en) Triazolopyridine compounds, compositions and methods of use thereof
EA201692289A1 (ru) Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов
EA201690716A1 (ru) ПИРИДО[2,3-d]ПИРИМИДИН-4-ОНОВЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ТАНКИРАЗЫ
MX2017007380A (es) Compuestos organicos.
WO2016014864A8 (en) Hydroxy-(r),(r)-2,2'-bismethylnaltrexones and uses thereof
EA201892585A1 (ru) 6-(БУТА-1,3-ДИИН-1-ИЛ)БЕНЗО[d]ТИАЗОЛЬНЫЕ ПРОИЗВОДНЫЕ
WO2016023522A3 (en) Substituted phosphoramidate compounds and uses thereof
EA201700037A1 (ru) Производные 2н-хромена в качестве анальгезирующих средств